期刊文献+

防治痛风药物筛选方法与药物作用机制研究 被引量:9

Discussion on the Prevention and Treatment of Gout Drug Screening Method and Pathogenesis
暂未订购
导出
摘要 目的:探讨防治痛风药物筛选方法以及现有机制。方法:通过查阅近年来文献,对已有的防治痛风药物筛选方法和相关机制研究进行归纳、分析。结果:目前防治痛风药物的筛选主要借助于动物模型,与人类痛风的发病机制尚有较大差距,药物的体外筛选模型尚未建立,借助动物模型进行的机制研究不深入。结论:现有的筛选方法有不足之处,机制研究尚处于探索阶段,需要对存在的问题进行改进。尤其是中药治疗痛风的作用机理较不明朗,急需探索出一套行之有效的更接近与人类痛风发病机制的模型进行系统研究。 Objective : To study the prevention and treatment of gout drug screening methods as well as the existing mechanism study of gout. Methods:concluded and analyzed the existing drug screening methods and related mechanisms research on prevention and treat- ment of gout, and discussed the prevention of gout drug screening methods and mechanisms by reviewing the literature in recent years. Results:At present, animal model is the primary method of prevention and treatment of gout drug screening, and there is still large difference with the human pathogenesis of gout. In vitro screening model has not already been established, and research on mechanism of gout is no in-depth. Conclusion :The existing screening method is inadequate, the mechanism research is still at an exploratory phase. We need to improve the existing problems. And especially the mechanism of traditional Chinese medicine in the treatment of gout is am- biguous, so we need to establish an animal model of gout for pathogenesis research and drug screen analysis.
机构地区 河南中医学院
出处 《中医学报》 CAS 2013年第12期1875-1878,共4页 Acta Chinese Medicine
基金 河南省高校科技创新团队(编号:2012IRTSTHN011) 药效评级工程技术中心[编号:教科技(2012)78-12] 中医药转化医学重点实验室(编号:121PYFZX182) 河南中医学院科技创新团队计划(编号:2010XCXTD03)
关键词 痛风 药物筛选 机制研究 动物模型 gout drug screening pathogenesis study animal model
  • 相关文献

参考文献21

二级参考文献233

共引文献384

同被引文献103

  • 1黄桂琼,陈洪,周迎春,刘彬,袁维蔚,谭章斌.牛大力防治尿酸性肾病的疗效及机制研究[J].中药材,2019,42(8):1907-1910. 被引量:17
  • 2刘佳,李文.原发性痛风及尿酸肾结石危险因素分析[J].中国现代医生,2007,45(07S):71-72. 被引量:5
  • 3任延明,文绍敦,洒玉萍,袁明.痛风中医证型病因病机调查分析[J].辽宁中医杂志,2007,34(7):872-873. 被引量:39
  • 4中华人民共和国卫生部药政管理局.中药新药研究指南(药学、药理学、毒理学[M].北京:人民卫生出版社,1994:254.
  • 5陈光亮,刘海鹏,韩茹,徐叔云.萆薢总皂苷合用牛膝总皂苷降血尿酸和抗炎作用的组方合理性研究[J].中国药理学通报,2007,23(11):1467-1471. 被引量:76
  • 6Saseen JJ,Agashivala N,Allen RR,et al.Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks[J].Rheumatology(Oxford),2012,51(11):2004-2012.
  • 7Castarlenas E,MiróJ,Sánchez-Rodríguez E.Is the verbal numerical rating scale a valid tool for assessing pain intensity in children below 8 years of age?[J].J Pain,2013,14(3):297-304.
  • 8Robinson PC,Merriman TR,Herbison P,et al.Hospital admissions associated with gout and their comorbidities in new zealand and england 1999-2009[J].Rheumatology(Oxford),2013,52(1):118-126.
  • 9Kuo CF,Yu KH,See LC,et al.Risk of myocardial infarction among patients with gout:A nationwide population-based study[J].Rheumatology(Oxford),2013,52(1):111-117.
  • 10Khanna D, Fitzgerald JD, Khanna PP,et al. 2012 American College of Rheumatology guidelines for management of gout[ J ]. Arthritis Care Res (Hoboken) ,2012,64(10) : 1431.

引证文献9

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部